Global Mineral And Bone Disorder Treatment Market Trends and Future Outlook to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Mineral And Bone Disorder Treatment Market?
In the last few years, there has been a significant growth in the market size of treatments for mineral and bone disorders. The market, valued at $3.3 billion in 2024, is set to expand to $3.54 billion in 2025, marking a compound annual growth rate (CAGR) of 7.4%. Contributing factors to this growth during the historic period include chronic kidney disease, an aging demographic, heightened awareness about mineral and bone disorders, increased accessibility to treatments for these disorders, and an upturn in disposable income levels.
The market size of treatments for mineral and bone disorders is predicted to experience robust growth in the impending years, reaching a valuation of $4.69 billion in 2029, boasting a compound annual growth rate (CAGR) of 7.3%. Factors stimulating growth within this period include the increasing need for life-enhancing treatments, a surging interest in tailor-made medical treatments, government investment in health services, and a heightened recognition of the significance of early medical screening. The forthcoming period is expected to be shaped by trends such as progress in medical research, advancements in pharmacy, the rise of digital health, the use of biologic therapies, and the advent of telehealth coupled with remote monitoring.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12956&type=smp
What Drivers Are Accelerating Expansion Of The Mineral And Bone Disorder Treatment Market?
The growth of the mineral and bone disorder treatment market is projected to be propelled by the growing elderly population. This group consists of individuals aged 65 and above, who commonly suffer from the loss of bone and muscle mass, leading to a decrease in strength and frailty. Treatments for mineral and bone disorders can counteract these age-related changes, fortify bones, and slow down the rate of bone loss. For example, the UK Parliament’s House of Commons Library, a government body in the UK, reported in July 2024 that by 2022, the UK will have 12.7 million people aged 65 or over, accounting for 19% of the population. This number is anticipated to increase to 22.1 million by 2072, comprising 27% of the total population. Consequently, the rising elderly population is fueling the expansion of the mineral and bone disorder treatment market.
What Are The Key Segment Trends Observed In The Mineral And Bone Disorder Treatment Market?
The mineral and bone disorder treatmentmarket covered in this report is segmented –
1) By Treatment: Diet; Nutrition; Medication; Supplements; Dialysis
2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Diet: Calcium-Rich Foods; Vitamin D-Enriched Foods; Phosphorus-Rich Foods
2) By Nutrition: Nutritional Counseling; Fortified Food Products; Meal Replacement Programs
3) By Medication: Bisphosphonates; Hormonal Therapies; RANK Ligand Inhibitors
4) By Supplements: Calcium Supplements; Vitamin D Supplements; Multivitamin Supplements
5) By Dialysis: Hemodialysis; Peritoneal Dialysis; Continuous Renal Replacement Therapy (CRRT)
What Strategic Shifts And Innovations Are Influencing The Mineral And Bone Disorder Treatment Market?
Prominent businesses in the bone and mineral disorder therapy market are concentrating on introducing new products and obtaining approval to build their market share. There’s a rise in approval for bone and mineral drugs owing to the aging population and the growing incidence of chronic kidney diseases such as osteomalacia. This includes drugs like TYMLOS (abaloparatide), which incorporates the active pharmaceutical ingredient abaloparatide, a synthetic version of human parathyroid hormone. For instance, in December 2022, Radius Health Inc., an American biopharmaceutical firm, obtained approval for TYMLOS (abaloparatide), a parathyroid hormone-associated peptide [PTHrP(1-34)] analog. It is intended to enhance bone density in men at high risk of osteoporosis fractures. It operates as a bone anabolic agent, selectively activating the parathyroid hormone 1 receptor (PTH1R) expressed in osteoblasts and osteocytes, resulting in enhanced bone formation and density.
Who Are The Major Stakeholders Operating In The Mineral And Bone Disorder Treatment Market?
Major companies operating in the mineral and bone disorder treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co. Ltd., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Servier Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd., Alembic Pharmaceuticals Limited, Ajanta Pharma Ltd., Abiogen Pharma Spa, Melinta Therapeutics Inc., Intas Pharmaceuticals Ltd., Radius Health Inc., EffRx Pharmaceuticals SA.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Mineral And Bone Disorder Treatment Market?
North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12956&type=smp
Browse Through More Reports Similar to the Global Mineral And Bone Disorder Treatment Market 2025, By The Business Research Company
Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Anemia And Other Blood Disorder Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
